Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma
- PMID: 28586488
- DOI: 10.1093/neuros/nyx105
Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma
Comment on
-
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.N Engl J Med. 2016 Dec 29;375(26):2561-9. doi: 10.1056/NEJMoa1610497. N Engl J Med. 2016. PMID: 28029927 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
